🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 3 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 22/11/2022 | 266,65 | 271,22 | 263,38 | 270,93 | +2,01% | 2,94% | 291.000 |
| 21/11/2022 | 265,05 | 269,38 | 263,11 | 265,59 | +0,37% | 2,37% | 248.300 |
| 18/11/2022 | 264,85 | 266,21 | 259,63 | 264,62 | -0,05% | 2,48% | 342.600 |
| 17/11/2022 | 260,35 | 265,36 | 257,47 | 264,75 | +1,42% | 3,03% | 350.200 |
| 16/11/2022 | 259,89 | 266,36 | 259,89 | 261,05 | +0,74% | 2,49% | 292.000 |
| 15/11/2022 | 256,80 | 261,34 | 255,01 | 259,12 | +1,76% | 2,46% | 362.800 |
| 14/11/2022 | 257,38 | 262,36 | 254,05 | 254,64 | -0,32% | 3,23% | 294.000 |
| 11/11/2022 | 264,03 | 264,03 | 251,54 | 255,45 | -3,01% | 4,73% | 499.200 |
| 10/11/2022 | 269,56 | 270,61 | 256,83 | 263,38 | -0,39% | 5,11% | 450.800 |
| 09/11/2022 | 262,59 | 267,14 | 260,03 | 264,41 | +0,60% | 2,71% | 354.000 |
| 08/11/2022 | 265,09 | 266,00 | 260,24 | 262,84 | -1,48% | 2,17% | 477.100 |
| 07/11/2022 | 263,11 | 270,43 | 262,67 | 266,80 | +0,80% | 2,95% | 477.600 |
| 04/11/2022 | 264,29 | 268,23 | 261,64 | 264,69 | -0,28% | 2,49% | 393.700 |
| 03/11/2022 | 255,02 | 270,44 | 253,95 | 265,42 | +4,64% | 6,47% | 795.600 |
| 02/11/2022 | 236,01 | 259,18 | 233,16 | 253,65 | +11,06% | 11,02% | 1.703.300 |
| 01/11/2022 | 230,28 | 234,10 | 227,90 | 228,39 | -0,93% | 2,69% | 401.100 |
| 31/10/2022 | 230,50 | 231,50 | 226,96 | 230,53 | -0,70% | 1,97% | 368.400 |
| 28/10/2022 | 227,31 | 232,98 | 225,19 | 232,15 | +2,81% | 3,43% | 299.700 |
| 27/10/2022 | 229,42 | 230,98 | 225,23 | 225,81 | -0,83% | 2,51% | 238.400 |
| 26/10/2022 | 228,11 | 231,82 | 226,82 | 227,70 | +0,41% | 2,19% | 270.500 |
| 25/10/2022 | 220,83 | 227,30 | 220,83 | 226,76 | +2,10% | 2,93% | 259.700 |
| 24/10/2022 | 219,58 | 224,03 | 218,82 | 222,09 | +1,27% | 2,37% | 265.800 |
| 21/10/2022 | 216,47 | 220,26 | 216,10 | 219,30 | +1,60% | 1,92% | 265.400 |
| 20/10/2022 | 216,88 | 217,53 | 214,53 | 215,85 | -0,34% | 1,38% | 194.500 |
| 19/10/2022 | 217,99 | 218,28 | 214,90 | 216,59 | -1,27% | 1,55% | 326.900 |
| 18/10/2022 | 223,54 | 224,28 | 219,07 | 219,38 | -1,17% | 2,33% | 293.700 |
| 17/10/2022 | 217,32 | 223,42 | 217,08 | 221,98 | +2,56% | 2,92% | 335.700 |
| 14/10/2022 | 214,27 | 217,93 | 214,27 | 216,44 | +1,25% | 1,71% | 275.700 |
| 13/10/2022 | 210,35 | 216,53 | 209,57 | 213,76 | +1,19% | 3,31% | 350.800 |
| 12/10/2022 | 212,07 | 212,58 | 209,48 | 211,25 | -0,11% | 1,46% | 221.900 |